Red, green, and blue model assessment and AQbD approach to HPTLC method for concomitant analysis of metformin, pioglitazone, and teneligliptin

Abstract Background The CDSCO of India has authorized a combination of metformin hydrochloride, teneligliptin hydrochloride, and pioglitazone hydrochloride for the treatment of insulin-independent diabetes. For the purpose of estimating metformin, teneligliptin, and pioglitazone combinations as well...

Description complète

Détails bibliographiques

Auteurs principaux:	Pintu Prajapati, Pooja Patel, Dhrumi Naik, Anzarul Haque, Shailesh Shah
Format:	Artigo
Langue:	Inglês
Publié:	SpringerOpen 2024-11-01
Collection:	Future Journal of Pharmaceutical Sciences
Sujets:	Metformin hydrochloride Teneligliptin hydrobromide hydrate Pioglitazone hydrochloride Analytical quality by design Response surface modeling
Accès en ligne:	https://doi.org/10.1186/s43094-024-00746-7
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!